US 11786524
Pharmaceutical compounds
granted A61KA61K31/4155A61K31/454
Quick answer
US patent 11786524 (Pharmaceutical compounds) held by SENTINEL ONCOLOGY LIMITED expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SENTINEL ONCOLOGY LIMITED
- Grant date
- Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/4155, A61K31/454, A61K31/497, A61K31/5377